2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Treatment choices for the "severe acute respiratory syndrome‐related coronavirus‐2 (SARS‐CoV‐2)" are inadequate, having no clarity on efficacy and safety profiles. Currently, no established intervention has lowered the mortality rate in the "coronavirus disease 2019 (COVID‐19)" p...
Saved in:
Main Authors: | Zoufang Huang (Author), Vivek P. Chavda (Author), Lalitkumar K. Vora (Author), Normi Gajjar (Author), Vasso Apostolopoulos (Author), Nirav Shah (Author), Zhe-Sheng Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
by: Vivek P. Chavda, et al.
Published: (2021) -
2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis.
by: Qi Xin, et al.
Published: (2022) -
Synergistic Effects of 2-Deoxy-D-Glucose and Cinnamic Acid with Erlotinib on NSCLC Cell Line
by: Wrood salim Al-khfajy, et al.
Published: (2023) -
Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose.
by: Patricia Sola Penna, et al.
Published: (2023) -
In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
by: Anirudh Pratap Singh Raman, et al.
Published: (2022)